Belyea to step down as Metabolic CEO
By Renate Krelle
Thursday, 13 January, 2005
Thursday, 13 January, 2005
Obesity drug-developer Metabolic (ASX:MBP) announced today that the company is searching for a new CEO and that when an appointment is made, founding CEO Chris Belyea will move into a "scientific and technical" role within the company.
The company said Belyea had expressed his desire to relinquish the CEO role in August 2004. Board chairman Arthur Emmett has since been undertaking the search for a new CEO.
Related News
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
